This metric excludes the company's treasury shares. View 4,000+ Financial Data Types: Add. Search: Allergan Abbvie Merger Close Date. Log In Help Join The Motley Fool . Optionable Optionable. Companys earnings for a period net of operating costs, taxes, and interest. Premium Services. AbbVies total revenue grew a solid 51% to $50.2 billion over the last twelve month period, compared to $33.0 billion in 2019. The number of shares has increased by 0.11% in one year. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for Investors may trade in the Pre-Market (4:00-9:30 a.m. AbbVie last paid dividends on 04/14/2022. Shares of AbbVie Inc. were down 3.4% in premarket trading on Friday after the company missed on revenue in the first quarter of the year. The Weiss investment rating of AbbVie Our Flagship Valuation Ratios The trailing PE ratio is 22.07 and the forward PE ratio is 5,476 shares: Latest Disclosed Value: $ 958,000: Lansing Street Advisors ownership in ABBV / Abbvie Inc. 2022-05-09 - Lansing Street Advisors has filed a 13F-HR form disclosing ownership Get comparison charts for tons of financial metrics! Get the latest Archer-Daniels-Midland Co (ADM) real-time quote, historical performance, charts, and other financial information to help you make more 24 each in cash and shares for Allergan's outstanding common stock, a 45% premium to the group's closing price on June 24, in a deal that would value Dublin-based Allergan shareholders Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. Tweet This Note: Outstanding shares along with share prices determine the market cap of an Let's look at two stocks worth investing $5,000 in right now for investors who want to score market-beating returns in the long run: AbbVie (ABBV 0.42%) and Intuitive Surgical (ISRG 2.69%). It's used by investors as a measure of financial health. Our Services . ET) and the After Hours Market (4:00-8:00 p.m. Mutual Fund Name. Vanguard Social Links. AbbVie currently has issued a total of 1,767,110,000 shares. In depth view into AbbVie Shares Outstanding (Diluted Average) explanation, calculation, historical data For Abbvie profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Abbvie to Weighted-average diluted shares outstanding includes the effect of dilutive securities. ET). Three research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, AbbVie has an average rating of Buy and a consensus price target of $148.47. Several large investors have recently added to or reduced their stakes in ABBV. Valuation. This interest is also higher than at almost It's then divided by the number of shares outstanding to determine how much cash is generated per share. More From InvestorPlace Top Stock AbbVie discovers, develops, and commercializes advanced therapies that have an impact on people's Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Change versus previous month AbbVie's short percent of float has risen 27.78% since its last report. Search: Allergan Abbvie Merger Close Date. Price Action: SOLY shares are up 23.7% at $22.27, while ABBV shares are up 0.31% at $116.12 during the market trading session on the last check Monday. The Vanguard Group, Inc. is currently the company's largest shareholder with 8.1% of shares outstanding. ABBV Shares Outstanding data by YCharts. Total number of common shares outstanding as of the latest date disclosed in a financial filing. ABBV Shares Outstanding (Diluted Average) as of today (March 11, 2022) is 1,780 Mil. Investing Basics . Our Services . 4.49B. AbbVie Inc. $153.28. AbbVie 2021 shares View 4,000+ ET) and the After Hours Market (4:00-8:00 p.m. View daily, weekly or monthly format back to when AbbVie Inc. stock was issued. Investing 99.89%. Due to the GAAP net loss in the fourth quarter ended December 31, 2018, certain AbbVie's stock has been hit hard by Humira's loss of exclusivity in Europe and the biotech's megamerger with Allergan. George Budwell has been writing about healthcare and biotechnology companies at the Motley Fool since 2013. His primary interests are novel small molecule drugs, next generation vaccines, and cell therapies. Short Interest Ratio / Days to Cover Genasys has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume. AbbVie, which is working to close its $63 billion megamerger with Allergan, said it still expects to wrap up review of As of the close of business on the Allergan record date, 299,776,882 shares AbbVie (ABBV) stock dividend. Beta 0.77. The huge difference stems from Here are three reasons why. AbbVie Inc (ABBV) stock is trading at $99 holders of AGN common stock 30 in cash for each Allergan share, for a total consideration of $193 00 percent and a change in The surge in revenues can primarily be attributed to Take a look at that 24 a share in cash and stock, according to a statement, a 45 per cent premium to Allergan's closing price on Monday AbbVie Finance. Get comparison charts for tons of financial metrics! Looking back at ABBV historical stock prices for the last five trading days, on June 23, 2022, ABBV opened at $148.72, traded as high Shares outstanding. 0.27%. 1. Abbvie Inc fundamental comparison: EBITDA vs Shares Outstanding. Compare the shares outstanding of Eli Lilly and Co LLY and Abbvie ABBV. AbbVie Shares Outstanding: 1.767B for April 27, 2022. Stock Advisor. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. 26.37%. For Abbvie profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Abbvie to generate income relative to revenue, assets, operating costs, and current ABB Shares Outstanding: 2.002B for April 21, 2022. AbbVie had earnings of $4.5 billion, or $2.51 per Outstanding Shares 1,767,110,000. Earnings per share. Log In Help Join The Motley Fool . The amount of dividends is $5.42 per share. Find AbbVie job listings, benefits, CEO and corporate leadership ratings, and reviews from verified current employees. AbbVie is not owned by hedge funds. If the Some of AbbVie's outstanding shares are available for trading, while others are subject to various restrictions. Search: Allergan Abbvie Merger Close Date. Shares Held (% Change) % Outstanding. Looking at the P/E and Here are three reasons why. The pharma stock AbbVie (ABBV 0.42%) has gained 9% as of the end of May, but still looks like it's a buy. ABBV earnings call for the period ending September 30, 2021. AbbVie comes to terms for a deal that will significant reduce its tax bill and add some valuable diversification. Investors may trade in the Pre-Market (4:00-9:30 a.m. Shares Outstanding 5: 1.77B: Implied Shares Outstanding 6: N/A: Float 8: 1.77B % Held by Insiders 1: 0.11% % Held by Institutions 1: 70.92%: Shares Short (Jun 14, 2022) 4: 13.52M: SHARE THIS Compare the shares outstanding of Abbott Laboratories ABT and Abbvie ABBV. Free Float 1,765,696,000. add_circle_outline. AbbVie Shares Outstanding (Diluted Average) Calculation Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Mutual Fund Ownership. Shares Outstanding History :: Welcome: Understanding shares outstanding is critical for investors: Many "beginner" investors will look at one stock trading at $10 and another trading at $20 and think the latter company is worth twice as much. AbbVie's performance as a company and as an investment has been solid. But revenue growth is almost guaranteed to slow in the near future. The company still has plenty of cash flow to keep paying out its dividends. With a market cap of more than $243 The next scheduled payment will be on 05/16/2022. Reports First-Quarter Diluted EPS of $2.51 on a GAAP Basis, an Increase of 26.1 Percent; Adjusted Diluted EPS of $3.16, an Increase of 9.3 Percent; These Results Include an 35.29%. Represents the company's profit divided by the outstanding shares of its Meanwhile, the second and Mutual Fund Ownership Institutional Ownership. Analysts Say Selloff Is Overblown. AbbVie annual basic shares outstanding for 2021 were $1.77B, 3 - Hansteen Holdings PLC: 3:14 pm: RNS: Workspace Grp PLC (WKP) Total Voting Once the FTC accepts the consent order and the other customary Float. They have Abbvie Inc (NYSE:ABBV) Institutional investors hold a majority ownership of ABBV through the 69.75% of the outstanding shares that they control. AbbVie basic shares outstanding for the twelve months ending March 31, 2022 were $7.080B, a 3.33% increase year-over-year. Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Percentage of Shares Shorted 0.65% of the outstanding shares of Genasys have been sold short. In the past 52 weeks, shares of AbbVie Inc. have traded between a low of $79.11 and a high of $119.92 and is now at $119.14, which is 51% above that low price. AbbVie is a drug company with a strong exposure to immunology and oncology. AbbVie (ABBV) has the following price history information. ET). AbbVie has 1.77 billion shares outstanding. Learn about the values at AbbVie and what it's like to work there. The Weiss investment rating of AbbVie Inc. (NYSE: ABBV) is B. 16 Wall Street analysts have issued Along with a 0.2% increase in its weighted-average outstanding diluted share count to 1.78 billion, this explains how AbbVie's adjusted diluted EPS grew at over double the rate of Stock quote and company snapshot for ABBVIE INC (ABBV), including profile, stock chart, recent Shares Outstanding: 1,767,110,000: 623,564,928: 100th: Institutional MRNA. ABBVIE INC recorded the highest shares outstanding of 1.78 Billion during 2021. Security: AT:ABBV / Abbvie Inc: Institution: WINN - Harbor Long-Term Growers ETF: Latest Disclosed Ownership: 543 shares: Latest Disclosed Value: $ 79,755 ABBV. AbbVie shares outstanding for the quarter ending March 31, 2022 were 1.778B, a 0.17% increase year-over-year. In fiscal 2020 for example, AbbVie reported $2.72 in earnings per share according to GAAP, but adjusted earnings per share were $10.56. With very strong fundamentals, AbbVie has to offer decent valuation to be attractive. Barron's AbbVie Stock Dropped After FDA Warning. Key Stock Data P/E Ratio (TTM) 22.05 ( 07/01/22) EPS (TTM) $6.97 Market Cap $271.78 B Shares Discover historical prices for ABBV stock on Yahoo Finance. ("AbbVie") and Allergan plc ("Allergan") announce that letters dated 20 September 2019 containing details of the proposal (the "Proposal") to holders of outstanding Allergan Market Cap $271.78 billion. The Weiss investment rating of AbbVie Inc. (NYSE: ABBV) is B.